$ISIS Recent Headlines S&P confirms uptrend, p
Post# of 44829
Posted On: 12/20/2014 11:55:57 AM
$ISIS Recent Headlines
S&P confirms uptrend, pulls in from record high 10:59 a.m. Nov. 19, 2014 - Michael Ashbaugh
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half 10:46 a.m. Dec. 19, 2014 - TheStreet.com
Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape 9:00 a.m. Dec. 19, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com
Jim Cramer's Top Stock Picks: BA MMM ISIS Q 6:00 a.m. Dec. 19, 2014 - TheStreet.com
Cramer's Mad Money - Which Biotech Is The Next Regeneron? (12/18/14) 5:45 a.m. Dec. 19, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally 8:10 p.m. Dec. 18, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock 6:39 p.m. Dec. 18, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's "Water-Logged And Getting Wetter" Stock 11:41 a.m. Dec. 15, 2014 - TheStreet.com
Why Linn Energy LLC, Yandex NV and ISIS Pharmaceuticals Are 3 of Today’s Worst Stocks 10:34 a.m. Dec. 15, 2014 - InvestorPlace.com
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (12/12/14) 6:42 a.m. Dec. 14, 2014 - Seeking Alpha
Value vs. Growth: Is Jim Cramer Right about ISIS Pharmaceuticals? 9:50 p.m. Dec. 13, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – CNC BLUE PBYI ISIS 6:45 a.m. Dec. 12, 2014 - InvestorPlace.com
New Lifetime High For Isis Pharmaceuticals (ISIS) 9:45 a.m. Dec. 11, 2014 - TheStreet.com
Jim Cramer's Top Stock Picks: RH COST AGIO BLUE ISIS 6:00 a.m. Dec. 11, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ISIS LLY ACHN LCI 5:30 a.m. Dec. 11, 2014 - InvestorPlace.com
Cramer's Mad Money - The Good Isis (12/10/14) 4:43 a.m. Dec. 11, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices 8:41 p.m. Dec. 10, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Is Strong On High Volume Today 10:13 a.m. Dec. 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com
ISIS Jumps on Positive Results for Venous Thrombosis Drug - Analyst Blog 6:35 p.m. Dec. 9, 2014 - Zacks.com
Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 7:00 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery 2:05 p.m. Dec. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award 7:00 a.m. Dec. 5, 2014 - PR Newswire - PRF
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine 5:05 p.m. Dec. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium 4:47 p.m. Nov. 20, 2014 - PR Newswire - PRF
Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association 3:45 p.m. Nov. 18, 2014 - BusinessWire - BZX
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 7:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award 12:04 p.m. Nov. 17, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes 7:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes 4:03 p.m. Nov. 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca 7:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
S&P confirms uptrend, pulls in from record high 10:59 a.m. Nov. 19, 2014 - Michael Ashbaugh
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half 10:46 a.m. Dec. 19, 2014 - TheStreet.com
Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape 9:00 a.m. Dec. 19, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com
Jim Cramer's Top Stock Picks: BA MMM ISIS Q 6:00 a.m. Dec. 19, 2014 - TheStreet.com
Cramer's Mad Money - Which Biotech Is The Next Regeneron? (12/18/14) 5:45 a.m. Dec. 19, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally 8:10 p.m. Dec. 18, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock 6:39 p.m. Dec. 18, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's "Water-Logged And Getting Wetter" Stock 11:41 a.m. Dec. 15, 2014 - TheStreet.com
Why Linn Energy LLC, Yandex NV and ISIS Pharmaceuticals Are 3 of Today’s Worst Stocks 10:34 a.m. Dec. 15, 2014 - InvestorPlace.com
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (12/12/14) 6:42 a.m. Dec. 14, 2014 - Seeking Alpha
Value vs. Growth: Is Jim Cramer Right about ISIS Pharmaceuticals? 9:50 p.m. Dec. 13, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – CNC BLUE PBYI ISIS 6:45 a.m. Dec. 12, 2014 - InvestorPlace.com
New Lifetime High For Isis Pharmaceuticals (ISIS) 9:45 a.m. Dec. 11, 2014 - TheStreet.com
Jim Cramer's Top Stock Picks: RH COST AGIO BLUE ISIS 6:00 a.m. Dec. 11, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ISIS LLY ACHN LCI 5:30 a.m. Dec. 11, 2014 - InvestorPlace.com
Cramer's Mad Money - The Good Isis (12/10/14) 4:43 a.m. Dec. 11, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices 8:41 p.m. Dec. 10, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Is Strong On High Volume Today 10:13 a.m. Dec. 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com
ISIS Jumps on Positive Results for Venous Thrombosis Drug - Analyst Blog 6:35 p.m. Dec. 9, 2014 - Zacks.com
Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 7:00 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery 2:05 p.m. Dec. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award 7:00 a.m. Dec. 5, 2014 - PR Newswire - PRF
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine 5:05 p.m. Dec. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium 4:47 p.m. Nov. 20, 2014 - PR Newswire - PRF
Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association 3:45 p.m. Nov. 18, 2014 - BusinessWire - BZX
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 7:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award 12:04 p.m. Nov. 17, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes 7:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes 4:03 p.m. Nov. 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca 7:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼